Skip to main content
NVDA+0.14%AAPL+0.02%GOOGL-0.63%MSFT-0.03%AMZN+0.24%TSM-3.01%SPCX-4.19%META-0.23%AVGO-4.35%TSLA-0.03%SKHY-4.35%MU+0.17%BRK-B+0.95%LLY-1.61%AMD-3.90%JPM+0.56%WMT+2.22%ASMLa+1.27%V+0.81%XOM+2.75%JNJ-0.76%INTC-5.34%MA+0.82%0700.HK+1.89%ABBV+0.39%CSCO-2.13%1398.HK-0.69%CVX+3.12%COST+0.60%AP2d-0.09%AMAT-2.13%LRCX-2.71%ORCL-5.48%DELL-0.76%BAC+0.17%KO+2.27%CAT-2.17%PG+1.87%1816.HK-26.47%UNH-1.34%3988.HK+1.12%0005.HK+1.80%GE+0.66%HSBA.L-1.95%PM+4.05%0857.HK+0.20%0939.HK+0.96%NFLX+2.68%MS-1.20%HD+3.39%AUDCHF+0.62%EURAUD-0.55%AUDJPY+0.52%EURCAD-0.50%CADCHF+0.47%USDTRY+0.44%GBPTRY+0.41%CADJPY+0.41%USDZAR-0.38%GBPAUD-0.36%AUDUSD+0.32%GBPHKD+0.32%GBPZAR-0.31%NZDCHF+0.31%EURNZD-0.31%GBPMXN-0.28%EURZAR-0.26%USDCAD-0.26%GBPCAD-0.25%NOKJPY+0.25%AUDNZD+0.24%NZDJPY+0.24%EURUSD-0.24%EURGBP-0.23%PLNJPY+0.23%USDCHF+0.22%GBPCHF+0.22%SGDJPY+0.21%NZDSGD+0.18%AUDSGD+0.18%NZDCAD-0.17%USDILS+0.16%NZDMXN+0.16%USDJPY+0.16%USDSEK-0.15%AUDNOK+0.14%GBPJPY+0.14%USDDKK-0.13%AUDDKK+0.13%USDNOK-0.13%EURHKD+0.12%USDPLN-0.11%EURJPY-0.10%USDMXN-0.10%USDCNH-0.10%NZDUSD+0.08%USDSGD-0.08%GBPNZD-0.08%CHFJPY-0.07%AUDCAD+0.05%CHFSGD+0.05%EURSGD+0.05%EURCNH+0.05%USDCOP-0.04%USDTHB-0.03%EURCZK+0.03%EURCHF-0.02%EURSEK-0.02%CHFSEK-0.02%EURPLN+0.01%EURDKK-0.01%USDHKD+0.01%GBPSGD+0.01%CHFNOK0.00%GBPUSD0.00%EURNOK0.00%XPTUSD+1.89%GAGUSD+1.65%XAGUSD+1.65%HG1+1.27%UKOIL-1.09%GAUUSD+1.08%XAUUSD+1.08%USOIL-0.94%S1+0.70%COTTON+0.51%C1+0.40%W1+0.35%BTCUSD-1.24%ETHUSD+11.79%USDTUSD-0.03%XRPUSD+5.55%SOLUSD+1.82%TRXUSDT-1.00%ZECUSDT-8.19%DOGEUSD+5.25%XMRUSDT-2.88%LINKUSD+7.35%XLMUSD-2.97%BCHUSDT-6.92%LTCUSD+1.20%UNIUSD-7.32%SUIUSD-6.71%HBARUSDT-1.59%TONUSD+18.86%TAOUSDT-6.41%AAVEUSD-5.07%DOTUSDT+3.45%ICPUSDT-6.73%ONDOUSDT+1.43%WLDUSDT-6.00%JUPUSDT-2.00%ARBUSDT-4.92%ATOMUSDT+8.61%STXUSDT+5.88%INJUSDT-6.95%FETUSDT-4.06%PYTHUSDT+11.19%TIAUSDT+11.01%SEIUSDT-3.41%IMXUSDT+5.69%GRTUSDT-3.74%OPUSDT-0.41%IOTAUSDT-5.19%WIFUSDT-8.72%AXSUSDT-5.15%POLUSDT-2.65%FARTCOINUSDT+0.68%EOSUSDT+0.74%DYDXUSDT+0.57%GALAUSDT-4.26%ORDIUSDT-6.29%RONINUSDT-2.67%NOTUSDT-5.84%NVDA+0.14%AAPL+0.02%GOOGL-0.63%MSFT-0.03%AMZN+0.24%TSM-3.01%SPCX-4.19%META-0.23%AVGO-4.35%TSLA-0.03%SKHY-4.35%MU+0.17%BRK-B+0.95%LLY-1.61%AMD-3.90%JPM+0.56%WMT+2.22%ASMLa+1.27%V+0.81%XOM+2.75%JNJ-0.76%INTC-5.34%MA+0.82%0700.HK+1.89%ABBV+0.39%CSCO-2.13%1398.HK-0.69%CVX+3.12%COST+0.60%AP2d-0.09%AMAT-2.13%LRCX-2.71%ORCL-5.48%DELL-0.76%BAC+0.17%KO+2.27%CAT-2.17%PG+1.87%1816.HK-26.47%UNH-1.34%3988.HK+1.12%0005.HK+1.80%GE+0.66%HSBA.L-1.95%PM+4.05%0857.HK+0.20%0939.HK+0.96%NFLX+2.68%MS-1.20%HD+3.39%AUDCHF+0.62%EURAUD-0.55%AUDJPY+0.52%EURCAD-0.50%CADCHF+0.47%USDTRY+0.44%GBPTRY+0.41%CADJPY+0.41%USDZAR-0.38%GBPAUD-0.36%AUDUSD+0.32%GBPHKD+0.32%GBPZAR-0.31%NZDCHF+0.31%EURNZD-0.31%GBPMXN-0.28%EURZAR-0.26%USDCAD-0.26%GBPCAD-0.25%NOKJPY+0.25%AUDNZD+0.24%NZDJPY+0.24%EURUSD-0.24%EURGBP-0.23%PLNJPY+0.23%USDCHF+0.22%GBPCHF+0.22%SGDJPY+0.21%NZDSGD+0.18%AUDSGD+0.18%NZDCAD-0.17%USDILS+0.16%NZDMXN+0.16%USDJPY+0.16%USDSEK-0.15%AUDNOK+0.14%GBPJPY+0.14%USDDKK-0.13%AUDDKK+0.13%USDNOK-0.13%EURHKD+0.12%USDPLN-0.11%EURJPY-0.10%USDMXN-0.10%USDCNH-0.10%NZDUSD+0.08%USDSGD-0.08%GBPNZD-0.08%CHFJPY-0.07%AUDCAD+0.05%CHFSGD+0.05%EURSGD+0.05%EURCNH+0.05%USDCOP-0.04%USDTHB-0.03%EURCZK+0.03%EURCHF-0.02%EURSEK-0.02%CHFSEK-0.02%EURPLN+0.01%EURDKK-0.01%USDHKD+0.01%GBPSGD+0.01%CHFNOK0.00%GBPUSD0.00%EURNOK0.00%XPTUSD+1.89%GAGUSD+1.65%XAGUSD+1.65%HG1+1.27%UKOIL-1.09%GAUUSD+1.08%XAUUSD+1.08%USOIL-0.94%S1+0.70%COTTON+0.51%C1+0.40%W1+0.35%BTCUSD-1.24%ETHUSD+11.79%USDTUSD-0.03%XRPUSD+5.55%SOLUSD+1.82%TRXUSDT-1.00%ZECUSDT-8.19%DOGEUSD+5.25%XMRUSDT-2.88%LINKUSD+7.35%XLMUSD-2.97%BCHUSDT-6.92%LTCUSD+1.20%UNIUSD-7.32%SUIUSD-6.71%HBARUSDT-1.59%TONUSD+18.86%TAOUSDT-6.41%AAVEUSD-5.07%DOTUSDT+3.45%ICPUSDT-6.73%ONDOUSDT+1.43%WLDUSDT-6.00%JUPUSDT-2.00%ARBUSDT-4.92%ATOMUSDT+8.61%STXUSDT+5.88%INJUSDT-6.95%FETUSDT-4.06%PYTHUSDT+11.19%TIAUSDT+11.01%SEIUSDT-3.41%IMXUSDT+5.69%GRTUSDT-3.74%OPUSDT-0.41%IOTAUSDT-5.19%WIFUSDT-8.72%AXSUSDT-5.15%POLUSDT-2.65%FARTCOINUSDT+0.68%EOSUSDT+0.74%DYDXUSDT+0.57%GALAUSDT-4.26%ORDIUSDT-6.29%RONINUSDT-2.67%NOTUSDT-5.84%
WP

West Pharmaceutical Services, Inc. (WST)

NYSE • Healthcare

$363.27
-$3.21 (-0.9%)
Market closed

Last close at October 8, 2026 at 20:00 UTC

Open$365.86
Day Range$359.55 - $367.25
Avg. Volume (3M)635.6K
Market Cap$25.5B
P/E Ratio46.2
52 Week Range
$223.83$386
Next EarningsIn 13 daysOct 22, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$872.3M100%
Gross Profitminus cost of goods$329.2M38%
Operating Incomeminus R&D and overhead$179.1M21%
Net Incomeminus taxes and the rest$154M18%

In plain terms: out of every $100 in revenue, West Pharmaceutical Services, Inc. keeps $18 as net profit.

Fundamentals & Financials

Revenue (TTM)
$3.3B
Net Income (TTM)
$564.9M
EPS (TTM)
$7.87
ROA (TTM)
13.86%
Current Ratio
2.82
Dividend Yield
0.062%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+11.5%Q1 2026$2.04
+26.8%Q2 2026$2.13
+13.9%Q3 2026$2.37
Next

Oct 22

in 13 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +13.9%

West Pharmaceutical Services beat both the top and bottom line in the second fiscal quarter of 2026, with results reported July 23, 2026: adjusted EPS of $2.37 topped the $2.08 estimate by +13.9%, and revenue of about $872.3 million exceeded the $840.0 million consensus by +3.8%. Revenue rose 14% from $766.2 million a year ago, while adjusted EPS increased 29% from $1.84. Net income climbed 17% to about $154.0 million from $131.8 million, and operating income came in at roughly $179.1 million as operating margin held near 21% after gross margin of about 38%. Operating cash flow reached about $124.0 million, and the company paid about $15.7 million in dividends. Next-period consensus calls for EPS of $2.14 on revenue of $820.2 million.

Next report — what to expect

West Pharmaceutical Services, Inc. (WST) reports on October 22, 2026. Wall Street is looking for consensus EPS of $2.18 on consensus revenue of $826.0 million. For trailing context, revenue grew +13.8% year over year last quarter. WST has beaten EPS in 8 of 8 most recent quarters, making expectations and any update to revenue growth a key watch.

View full earnings history

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (NYSE: WST) makes containment and delivery products for injectable medicines and related healthcare uses, operating in the medical instruments and supplies business. The company generated $3.1 billion in FY2025 revenue. Its business centers on components for injectable packaging, advanced drug administration systems, and contract-made medical devices.

Name
West Pharmaceutical Services, Inc.
CEO
Michel Lagarde
Website
www.westpharma.com
Industry
Healthcare
Year Founded
1923
Employees
10,800

Today's Snapshot

AI-generated

WST closed 0.9% below yesterday's close, while its sector was flat. WST reports earnings on 22 October.

Trading Volume

Below 10d avg (505.2K)

354.1K

vs S&P 500 Today

Moderate Underperformance

-0.36%

Updated: October 8, 2026 at 20:07 UTC

WST Headlines

DACH-Focused Stock Moves Across Key Sectors

March 21, 2026

5 min read
View All News

Technical Indicators

3 Buy3 Neutral2 Sell
WST exhibits characteristics of an uptrend despite a short-term pullback: ADX above 30 signals a reasonably strong trend while the stock currently trades below its 10- and 20-day averages but comfortably above the 50- and 200-day levels, indicating the pullback is occurring within a longer-term advance. Momentum measures are muted to mixed and MACD is positive but not extreme, while ATR points to moderate volatility and OBV shows lagging volume. Together these factors support a bullish structural bias even as near-term momentum softens. Technical takeaway: Buy — trend remains intact despite short-term weakness.
All signals
  • EMA (5 indicators)$312.69 - $368.30
    Buy
  • RSI (14)50.25
    Neutral
  • Stochastic %K (14, 3, 3)34.29
    Neutral
  • MACD Level (12, 26)4.60
    Neutral

Peers & Related Assets

ATRAptarGroup, Inc.
$121.81+1.1%
ICUIICU Medical, Inc.
$157.18+0.7%
BLFSBioLife Solutions, Inc.
$38.61+3.5%
SOAGYSartorius AG ADR
SDMHFSartorius Stedim Biotech S.A.
STVNStevanato Group S.p.A.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.